Originally published by our sister publication Specialty Pharmacy Continuum
By Gina Shaw
One year after a 2022 Supreme Court decision that the Centers for Medicare and Medicaid Services (CMS) did not have the authority to lower reimbursement rates to hospitals participating in the federal 340B drug discount program, CMS has proposed to pay the hospitals back for years of reduced payments with a one-time $9 billion lump sum in restitution.